All Stories

  1. Discovery of most conserved epitope regions in COVID-19 virus from across the globe.
  2. A nucleotide-dependent oligomerization of the Escherichia coli replication initiator DnaA requires residue His136 for remodeling of the chromosomal origin
  3. Recent advances with Treg depleting fusion protein toxins for cancer immunotherapy
  4. Second-generation IL-2 receptor-targeted diphtheria fusion toxin exhibits antitumor activity and synergy with anti–PD-1 in melanoma
  5. Repurposing of Carbapenems for the Treatment of Drug-Resistant Tuberculosis
  6. Mechanism based drug discovery against Mycobacterium abscessus by targeting L,D-transpeptidases
  7. LdtMav2, a nonclassical transpeptidase and susceptibility of Mycobacterium avium to carbapenems
  8. Structural insight into the inactivation of Mycobacterium tuberculosis non-classical transpeptidase LdtMt2 by biapenem and tebipenem
  9. Carbapenem drug resistance mechanism in Mycobacterium tuberculosis
  10. Inhibition of innate immune cytosolic surveillance by an M. tuberculosis phosphodiesterase
  11. Crystal structure of Mycobacterium tuberculosis L,D-transpeptidase 2 with carbapenem drug T224
  12. Development of new antibiotics for treatment of drug resistant Tuberculosis
  13. Crystal structure of Mycobacterium tuberculosis L,D-transpeptidase 2 with carbapenem drug T208
  14. Crystal structure of Mycobacterium tuberculosis L,D-transpeptidase 2 with carbapenem drug T210
  15. Crystal structure of Mycobacterium tuberculosis L,D-transpeptidase 2 with carbapenem drug T206 in conformation A
  16. Role of a non-canonical surface of Rad6 in ubiquitin conjugating activity
  17. Structure of the yeast Bre1 RING domain
  18. The crystal structure reveals the molecular mechanism of bifunctional 3,4-dihydroxy-2-butanone 4-phosphate synthase/GTP cyclohydrolase II (Rv1415) fromMycobacterium tuberculosis
  19. Corrigendum to “Structural basis for pH dependent monomer–dimer transition of 3,4-dihydroxy 2-butanone-4-phosphate synthase domain from Mycobacterium tuberculosis” [J. Struct. Biol. 174 (2011) 374–384]
  20. Structural basis for pH dependent monomer–dimer transition of 3,4-dihydroxy 2-butanone-4-phosphate synthase domain from Mycobacterium tuberculosis
  21. Crystal structure analysis of icosahedral lumazine synthase fromSalmonella typhimurium, an antibacterial drug target
  22. Potential anti-bacterial drug target: Structural characterization of 3,4-dihydroxy-2-butanone-4-phosphate synthase from Salmonella typhimurium LT2